177 related articles for article (PubMed ID: 1356150)
1. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
Jenck F; Moreau JL; Bonetti EP; Martin JR; Haefely WE
J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
[TBL] [Abstract][Full Text] [Related]
2. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
3. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
Facklam M; Schoch P; Bonetti EP; Jenck F; Martin JR; Moreau JL; Haefely WE
J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
[TBL] [Abstract][Full Text] [Related]
4. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
[TBL] [Abstract][Full Text] [Related]
5. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
Bernard PS; Bennett DA; Pastor G; Yokoyama N; Liebman JM
J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
[TBL] [Abstract][Full Text] [Related]
7. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
[TBL] [Abstract][Full Text] [Related]
9. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor.
Martin JR; Pieri L; Bonetti EP; Schaffner R; Burkard WP; Cumin R; Haefely WE
Pharmacopsychiatry; 1988 Nov; 21(6):360-2. PubMed ID: 2907644
[No Abstract] [Full Text] [Related]
10. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
[TBL] [Abstract][Full Text] [Related]
11. CGS 20625, a novel pyrazolopyridine anxiolytic.
Williams M; Bennett DA; Loo PS; Braunwalder AF; Amrick CL; Wilson DE; Thompson TN; Schmutz M; Yokoyoma N; Wasley JW
J Pharmacol Exp Ther; 1989 Jan; 248(1):89-96. PubMed ID: 2563294
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
13. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
[TBL] [Abstract][Full Text] [Related]
15. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
[TBL] [Abstract][Full Text] [Related]
16. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
Keane PE; Simiand J; Morre M; Biziere K
J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist.
Simiand J; Keane PE; Barnouin MC; Keane M; Soubrié P; Le Fur G
Fundam Clin Pharmacol; 1993; 7(8):413-27. PubMed ID: 7904976
[TBL] [Abstract][Full Text] [Related]
18. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.
Schoch P; Moreau JL; Martin JR; Haefely WE
Biochem Soc Symp; 1993; 59():121-34. PubMed ID: 7910739
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
